Balancing efficacy and safety of drug-eluting stents in patients undergoing percutaneous coronary intervention

Annals of Internal Medicine

Volumn 148, Issue 3, 2008, Pages 234-238

  Jeremias, Allen ^a   Kirtane, Ajay ^b  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; PACLITAXEL; RAPAMYCIN;

BARE METAL STENT; CLINICAL TRIAL; CORONARY ARTERY OBSTRUCTION; DATA ANALYSIS; DRUG ELUTING STENT; DRUG SAFETY; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; MEDICAL RESEARCH; PACLITAXEL ELUTING STENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RESTENOSIS; REVIEW; RISK ASSESSMENT; SIROLIMUS ELUTING STENT; STENT; THERAPY EFFECT; THROMBOSIS; TREATMENT OUTCOME; INSTRUMENTATION; METHODOLOGY; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; HUMANS;

EID: 39349102253     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-148-3-200802050-00199     Document Type: Review

References (27)